ProQR Therapeutics (PRQR) Retained Earnings (2013 - 2025)

ProQR Therapeutics has reported Retained Earnings for 13 years, with the latest figure at -$544.2 million in Q4 2025.

• Quarterly Retained Earnings fell 19.22% year-over-year to -$544.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$544.2 million (down 19.22% YoY) and the FY2025 annual result came in at -$544.2 million, down 19.22% from the prior year.
• Retained Earnings retreated to -$544.2 million in Q4 2025 per PRQR's latest filing, from -$456.5 million in the prior quarter.
• Over five years, Retained Earnings peaked at -$363.5 million in Q4 2021 and troughed at -$544.2 million in Q4 2025.
• A 5-year average of -$436.5 million and a median of -$431.3 million in 2023 frame the typical range for Retained Earnings.
• The sharpest annual moves came in 2024 and 2025: Retained Earnings fell 5.84% in 2024, then decreased 19.22% in 2025.
• Over 5 years, Retained Earnings stood at -$363.5 million in 2021, then declined by 6.4% to -$386.8 million in 2022, then fell by 11.51% to -$431.3 million in 2023, then dropped by 5.84% to -$456.5 million in 2024, then slipped by 19.22% to -$544.2 million in 2025.
• According to Business Quant data, Retained Earnings over the past three periods registered -$544.2 million, -$456.5 million, and -$431.3 million for Q4 2025, Q4 2024, and Q4 2023 respectively.